ASCC Initiates Trials on Biomolecule Skin Cream
September 24 2012 - 4:00AM
Business Wire
After receiving its first samples of Regenetech’s miraculously
rejuvenating biomolecule skin cream last week, the Aristocrat Group
Corp. (OTCBB: ASCC) announced today that it has initiated panel
testing on the product to collect first hand testimonials for
marketing.
Regenetech created the cream using NASA bioreactor technology
developed for the space program. The device produces rejuvenating
biomolecules as a byproduct of expanding, or multiplying, adult
stem cells. These cytokines, peptides and proteins have been shown
to dramatically reduce the appearance of wrinkles, age spots and
sagging—results ASCC hopes to reproduce in our panel testing.
ASCC believes Regenetech’s skin-care line could be the key to
capitalizing on the booming cosmetics market not only in the U.S.,
but across the globe. As the world’s population grows older, many
predict that the market for anti-aging cosmetics could double.
“We’re particularly impressed with Regenetech’s product because
it’s made using patented NASA technology, meaning it can’t be
reproduced by competitors,” said ASCC CEO Cindy Morrissey. “We
expect our market testing to confirm its desirability, and when it
does, we plan to move forward with negotiations toward a definitive
agreement.”
ASCC plans to expand its cosmetics business to compete in a
highly profitable sector alongside Procter & Gamble (NYSE: PG),
Unilever (NYSE: UL) and Avon Products, Inc. (NYSE: AVP).
Follow ASCC on Twitter
at www.twitter.com/AristocratGroup.
About the Aristocrat Group
The Aristocrat Group
Corp. (www.aristocratgroupcorp.com) is a women’s lifestyle
company that aims to make the transition into parenthood smoother
and more rewarding than ever before. Our smart growth initiatives
will position us as the premier resource for prenatal and
postpartum resources. For more information on our business plan,
please
visit www.aristocratgroupcorp.com/old/investor.html.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release contains forward-looking
information within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including statements that include the words
"believes," "expects," "anticipate" or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the company to differ materially
from those expressed or implied by such forward-looking statements.
In addition, description of anyone's past success, either financial
or strategic, is no guarantee of future success. This news release
speaks as of the date first set forth above and the company assumes
no responsibility to update the information included herein for
events occurring after the date hereof.
Aristocrat (PK) (USOTC:ASCC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aristocrat (PK) (USOTC:ASCC)
Historical Stock Chart
From Jul 2023 to Jul 2024